Rising Demand For Cancer Treatment Drives Market Growth Is Supporting Development Across The Corticosteroids Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The Corticosteroids Market Become By 2030 Compared To 2026?

The corticosteroids market has observed significant growth in recent years. Its valuation is anticipated to increase from $5.93 billion in 2025 to $6.33 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical expansion can be attributed to factors such as the increasing prevalence of asthma and allergies, the proven clinical effectiveness of corticosteroids, widespread implementation of steroid therapies in hospitals, enhanced awareness of inflammatory disease management, and the growth in pharmaceutical manufacturing capabilities.

The corticosteroids market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $8.34 billion, growing at a compound annual growth rate (CAGR) of 7.1%. This projected growth is driven by several factors, including an increasing prevalence of autoimmune and respiratory diseases, the creation of safer steroid products, an expanding global elderly population, improved healthcare accessibility in developing nations, and enhanced funding for corticosteroid studies. Key developments expected during this period encompass the introduction of targeted corticosteroid products, therapies involving lower doses and shorter durations, an increase in topical and inhaled corticosteroid use, combination treatments with bronchodilators, and broader application in emergency respiratory care.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Major Growth Factors Are Impacting The Corticosteroids Market?

The expanding need for cancer therapies is set to drive the growth of the corticosteroid market in the future. Cancer treatment involves diverse approaches like surgery, chemotherapy, radiation, immunotherapy, and targeted therapies, all aimed at eliminating cancer cells and mitigating symptoms. This increasing demand for cancer care stems from factors such as a higher incidence of cancer, enhanced public awareness and screening programs, better access to healthcare services, and the provision of supportive care. Corticosteroids contribute to better patient outcomes by easing symptoms and making cancer treatments more tolerable, which in turn reinforces the growing need for extensive cancer care. For example, in May 2024, the National Health Service (NHS), the UK’s healthcare system, reported record-high treatment activity, with more than 1,400 patients starting cancer treatment daily. Additionally, between April 2023 and March 2024, close to 340,000 individuals began their initial cancer treatment. Consequently, the escalating demand for cancer treatment fuels the expansion of the corticosteroid market.

What Are The Core Segment Classifications In The Corticosteroids Market?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

Which Trends Are Shaping The Corticosteroids Market Landscape?

Leading companies in the corticosteroids market are developing innovative products like rescue medications to cater to larger customer bases, boost sales, and increase revenue. A rescue medication refers to a type of treatment or drug that provides quick, immediate relief from severe and acute symptoms of a medical condition or a sudden worsening of a chronic condition. For instance, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for Airsupra (albuterol/budesonide). A distinctive characteristic of this product is its classification as the first-in-class pressurized metered-dose inhaler (pMDI), which is a fixed-dose combination rescue medication. It contains albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) with anti-inflammatory properties. This product is indicated for individuals aged 18 years and older and can be used on an as-needed basis for the treatment or prevention of bronchoconstriction. It also assists in lowering the risk of asthma exacerbations. This combination is available in the United States and is currently under development by AstraZeneca in collaboration with Avillion.

Who Are The Prominent Players Across The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Access The Complete Corticosteroids Market Report:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Region Accounts For The Highest Share Of The Corticosteroids Market?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Corticosteroids Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795